Skip to content
The Kids Research Institute Australia logo
Donate

Search

Research

Early mental health morbidity and later smoking at 17 years of age

We examined the relationship between the onset and pattern of childhood mental health disorders and subsequent current smoking status at age 17 years.

News & Events

The Kids researchers who helped identify rare disorder now poised to help the hunt for treatment

Two The Kids Research Institute Australia researchers recognised for their role in building a global database for CDKL5 deficiency disorder are now helping to set the scene for clinical trials of much-needed potential treatments.

News & Events

Watershed approach to improve cystic fibrosis treatment

The Kids researchers are pioneering an exciting new approach to clinical trials, which aims to fast-track the best treatments for people with rare and complex diseases.

News & Events

National Asthma Week: 10 things you need to know about asthma

Asthma affects about half a million Australian children and is one of the most common reasons why kids need to see a doctor or go to emergency.

The facts

On average, a person can expect to take more than 700 million breaths in their lifetime.

Asthma

Respiratory disease is a global issue and international networks are critical to informing best-practice approaches to the clinical care and management of childhood respiratory health.

Cystic Fibrosis

Cystic fibrosis (CF) is the most common life‐shortening genetic disease affecting children.

Clinical Trials, Platforms & Cohorts

Learn more about all of the Clinical Trials, Platforms & Cohorts at the Wal-yan respiratory centre.

Community-led healthy skin materials on track to curb Strep A

Healthy skin is a vital factor in the fight against life-threatening conditions like sepsis, heart disease and kidney disease, all of which can be caused by the bacteria Strep A.

Research

SNAP-PY

There are an estimated 5000 episodes per year of bloodstream infections due to Staphylococcus aureus (golden staph) in Australia and an associated mortality of 20%. Despite this, there is little clinical trials evidence to guide best management.